Rocket Pharmaceuticals ( NASDAQ:RCKT – Get Rating ) posted its quarterly earnings results on Thursday. The biotechnology company reported ($0.73) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.84) by $0.11, Briefing.com reports. During the same quarter last year, the business posted ($0.67) EPS. Rocket Pharmaceuticals Stock Up 12.1 % NASDAQ:RCKT traded up $2.26 during trading hours on Friday, reaching $20.95. The company had a trading volume of 839,680 shares, compared to its average volume of 820,349.

https://www.dailypolitical.com/2023/05/05/rocket-pharmaceuticals-nasdaqrckt-posts-quarterly-earnings-results-beats-expectations-by-0-11-eps.html

#dailypolitical